The Bcl-2 family of proteins plays a key role in the regulation of apoptosis. Some family members prevent apoptosis induced by a variety of stimuli, whereas others promote apoptosis. Competitive dimerisation between family members is thought to regulate their function. Homologous domains within individual proteins are necessary for interactions with other family members and for activity, although the specific mechanisms might differ between the pro-apoptotic and anti-apoptotic proteins.
Background
Programmed cell death (PCD) plays an essential role in the development and tissue homeostasis of metazoan organisms [1] . Inappropriate PCD may disrupt these processes, leading to disease, whereas resistance to the induction of PCD contibutes to cancer [2] . Most cells undergoing PCD exhibit similar and dramatic morphological changes, including plasma membrane blebbing, cytoplasmic reorganisation, chromatin condensation and DNA fragmentation. These morphological changes and their underlying molecular mechanisms constitute the process known as apoptosis [3] .
The Bcl-2 oncoprotein delays or prevents apoptosis triggered by a variety of stimuli and permits cell survival [4] , indicating that it acts at a common control point in the cell death/survival pathway. There is remarkable conservation of Bcl-2 function across species [5, 6] , suggesting that Bcl-2 controls an evolutionarily conserved mechanism. Bcl-2 is one of a family of related proteins found in mammalian cells, some of which function as suppressors of apoptosis whereas others promote it [4] . Bcl-2 acts in a biochemical pathway upstream of members of the caspase family of cysteine proteases, regulating their activation [7] [8] [9] . Caspases cleave substrates thought to mediate the dramatic restructuring of the cell during apoptosis [10] . Caspases are themselves activated by proteolytic cleavage of their inactive precursors; one mechanism by which caspases are activated involves the release of cytochrome c from mitochondria in response to death-inducing signals. Bcl-2 and Bcl-x L block cytochrome c release [11] [12] [13] [14] . A homologue of the Caenorhabditis elegans CED-4 protein interacts with Bcl-2 family proteins, caspase precursors, cytochrome c and additional factors which participate in caspase activation [15, 16] .
Although proteins of the Bcl-2 family can have opposing biological effects, they share regions of sequence similarity known as Bcl-2 homology (BH) domains [9, 17, 18] . It has been proposed that these proteins are regulated through their ability to interact and form homodimers or heterodimers [19] . It has been unclear, however, whether the anti-apoptotic or pro-apoptotic proteins, or both, are the effector molecules that would be inhibited by association with an opposing partner. Deletion analysis has shown that the BH1, BH2 and BH3 domains are all required for anti-apoptotic activity of death-inhibiting members of the family when they are transfected into cells and for heterodimerisation with death-promoting members of the family [18, 20] . In contrast, the BH3 domain of Bax and of Bak is is the only region which, when deleted, abolishes both heterodimerisation with Bcl-2 and Bcl-x L and the ability to promote cell death [17, 21] . Moreover, the BH3 domain of Bak is sufficient to cause cell death when transfected into cells [17] . Other pro-apoptotic proteins have been described, such as Hrk, Bid and Nbk/Bik, which share homology with other Bcl-2 family members only in the BH3 domain [22] [23] [24] [25] . Together, these results suggest that BH3 domains are critical for the induction of apoptosis by pro-apoptotic Bcl-2 family members, although the mechanism is still uncertain.
Recently, we and others have characterised a cell-free system based on extracts of Xenopus eggs that reproduce morphological and biochemical events characteristic of apoptosis [8, [26] [27] [28] [29] . In this system, spontaneous activation of caspases occurs after a lag period of several hours [8] . The mechanism of caspase activation is unclear, but it involves the release of cytochrome c from mitochondria that are present in the extracts [13] . Cytochrome c release, caspase activation and apoptosis are all inhibited by addition of Bcl-2 [8, 13, 26] or Bcl-x L [27] . Xenopus egg extracts, therefore, provide a useful biochemical system with which to study the regulation of apoptosis by the Bcl-2 family of proteins.
In this study, we have used Xenopus egg extracts to study the function of BH3 domains from Bcl-2 family members. BH3 domains from Bax and Bak were found to induce the release of cytochrome c from mitochondria, triggering caspase activation and apoptosis in this system, whereas the BH3 domain from Bcl-2 was found to be ineffectual. Pro-apoptotic BH3 domains bind to Bcl-2 and antagonise its function, possibly by directly neutralising its anti-apoptotic activity. In addition, peptides derived from pro-apoptotic BH3 domains were found to be sufficient for caspase activation; this observation may provide the basis for engineering reagents to control the initiation of apoptosis.
Results
In order to elucidate further the molecular basis of the activity of Bcl-2 family members, in particular, the proapoptotic proteins, we have investigated the role of BH3 domains in the regulation of apoptosis. We produced a glutathione-S-transferase (GST) fusion protein containing the BH3 domain from Bak (amino acids 71-123) and tested its ability to control apoptosis in Xenopus egg extracts. Human HeLa cell nuclei were added to the extracts to provide markers of nuclear events. In the absence of the GST-Bak BH3 fusion protein, DNA cleavage into oligonucleosomal fragments ( Figure 1a ) and chromatin condensation (data not shown) typical of apoptosis occurred between 3 and 4 hours of incubation. Addition of GST-Bak BH3 to the extracts to a final concentration of 0.1 mg/ml accelerated greatly the timing and amount of DNA fragmentation (Figure 1a ), whereas Bcl-2 protein completely blocked fragmentation, as has been shown previously [8, 26] . Control incubations, GST alone and unrelated GST fusion proteins had no effect, whereas GST-Bak BH3 was still effective at triggering caspase activation at a final concentration of 0.01 mg/ml (data not shown). A similar acceleration of DNA fragmentation was obtained using GST fusion proteins containing the BH3 domain of Bax (amino acids 50-78 and 50-105; data not shown).
Previously, we have shown that DNA fragmentation occurring spontaneously after prolonged incubation of egg extracts is dependent on the activation of one or more caspases of the class potently inhibited by the tetrapeptide derivative Ac-DEVD-CHO [8] . Similarly, the rapid induction of DNA fragmentation in response to GST-Bak BH3 (Figure 1b ) or GST-Bax BH3 (data not shown) was completely blocked by Ac-DEVD-CHO. Furthermore, addition of these BH3 domains to egg extracts resulted in the rapid activation of caspases, as determined by assaying cleavage of the substrate poly (ADP-ribose) polymerase (PARP; Figure 1c ) or by cleavage of a fluorogenic substrate, Ac-DEVD-AMC ( Figure 1d ). Upon incubation at 23°C, control extracts exhibited spontaneous caspase activation after a 2-3 hour lag period (Figure 1c,d ). However, in the presence of GST-Bak BH3 or GST-Bax BH3 proteins, activation of caspases occurred within 30 minutes of the start of the incubation (Figure 1c,d ). Rapid activation of caspases was also observed when a 29 amino-acid peptide derived from the Bax BH3 domain (amino acids 50-78) was added to the egg extracts (data not shown). In contrast to BH3 domains from Bax and Bak, addition of GST-Bcl-2 BH3 (amino acids 86-111) had no effect, caspase activation occurring with the same kinetics as in control extracts ( Figure 1d ). Likewise, no effect of GST-Bcl-2 BH3 was observed on the timing or extent of DNA fragmentation, even at high concentrations (1 mg/ml; data not shown), although intact Bcl-2 completely blocks caspase activation (see below and [8] ) and DNA fragmentation ( Figure 1a ).
Previous studies have shown that a 16 amino-acid region of the Bak BH3 domain (amino acids 72-87) is sufficient for binding to Bcl-x L [30] . We therefore investigated whether this region is also sufficient for pro-apoptotic activity. Peptides of 16 amino acids derived from the BH3 regions of Bak, Bax or Bid (Table 1) caused rapid activation of caspases in Xenopus egg extracts ( Figure 2) . To test the possible relationship between binding to Bcl-x Land, by extension, probably to other anti-apoptotic Bcl-2 family proteins -and ability to trigger caspase activation, we used a peptide derived from Bak BH3 with a single amino-acid substitution (Leu 78→Ala; Table 1 ). This substitution, which reduces the affinity of the Bak BH3 peptide for Bcl-x L by about 800-fold [30] , abolished the effect on caspase activity. In addition, a peptide derived from the BH3 domain of Bcl-2 had no effect upon activation of caspases ( Figure 2 ).
These results suggest that pro-apoptotic BH3 domains act by binding endogenous Bcl-2 homologues in egg extracts.
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Figure 2
Peptides from pro-apoptotic BH3 domains trigger caspase activation in Xenopus egg extracts. Peptides from the BH3 domains of Bax, Bak, Bid, Bcl-2 or a mutant Bak peptide (L78A) were added to egg extracts to a final concentration of 0.1 mg/ml. At the times shown, samples were removed and analysed for cleavage of the fluorogenic substrate Ac-DEVD-AMC. Although Bcl-2 homologues have been identified in Xenopus [31] , they have not been characterised at the level of protein expression. To test binding of the GST-BH3 fusion proteins to Bcl-2 family proteins, we compared the ability of each GST-BH3 fusion protein to precipitate in vitro translated Bax, Bak, Bcl-2 or Bcl-x L . GST-Bak BH3 was able to bind to all four Bcl-2 family proteins (Figure 3a ), but not to other proteins such as caspases in control precipitations (data not shown). GST-Bax BH3 bound to Bcl-2, Bcl-x L and Bax, but not Bak. In contrast, GST-Bcl-2 BH3 was only able to bind to Bcl-x L in this assay. GST alone failed to precipitate any of the tested proteins ( Figure 3a ).
Pre-binding of Bcl-2 protein to GST-Bak BH3 fusion protein or simultaneous addition of equimolar amounts of the two proteins to the egg extracts neutralised the antiapoptotic effect of Bcl-2 ( Figure 3b ). Indeed, spontaneous caspase activation occurred with very similar kinetics in the presence or absence of a 1:1 ratio of Bcl-2:GST-Bak BH3. When Bcl-2 was added at a two-fold excess over GST-Bak BH3, inhibition of caspase activity was BH3 domains require both cytosolic and membrane components to trigger caspase activation. Egg extracts were thawed and immediately subjected to high speed centrifugation (100,000 × g). Membrane fractions were washed in membrane buffer before incubation alone (HM), with GST-Bak BH3 (HM + BH3), high-speed supernatant fractions (HS) or high-speed supernatant and GST-Bak BH3 (HS + HM + BH3). High-speed supernatant was also incubated alone (HS) or with GST-Bak BH3 (HS + BH3). At the times shown, samples were removed and caspase activity assayed using Ac-DEVD-AMC as a substrate. observed, whereas a two-fold excess of GST-Bak BH3 triggered caspase activation (Figure 3b ). These results suggest that pro-apoptotic BH3 domains bind to and inactivate anti-apoptotic Bcl-2 family proteins; presumably, an excess of Bak BH3 interacts with Bcl-2 homologues in the extracts to trigger apoptosis.
The spontaneous activation of caspases in Xenopus egg extracts requires a heavy membrane fraction that includes mitochondria [26] . We therefore tested whether intracellular membranes are also required for the pro-apoptotic activity of BH3 domains. Egg extracts were separated by high-speed centrifugation into a heavy membrane fraction containing mitochondria (HM) and a post-mitochondrial high-speed supernatant (HS). The HS and HM fractions did not show caspase activity when incubated separately ( Figure 4) . However, when extracts were reconstituted by mixing the two fractions, the spontaneous activation of caspases usually observed after 3 hours incubation was restored. Addition of GST-Bak BH3 to either the HS fraction or the HM fraction alone failed to trigger caspase activation. However, GST-Bak BH3 accelerated caspase activation in reconstituted extracts, indicating a requirement for both membrane and cytosolic components for GST-Bak BH3 pro-apoptotic activity.
In Xenopus egg extracts, cytochrome c has been shown to be slowly released from mitochondria causing the spontaneous activation of caspases after prolonged incubation [13] . One possible mechanism for the rapid caspase activation by BH3 domains might involve the triggering of cytochrome c release from mitochondria. When egg extracts containing mitochondria were incubated at 23°C and subjected to high-speed centrifugation, spontaneous release of cytochrome c and the coincident appearance of caspase activity in the post-mitochondrial supernatant (HS) occurred approximately 3-4 hours after the start of the incubation (Figure 5a ). Addition of Bcl-2 protein completely prevented the release of cytochrome c and caspase activation, as has been found previously [13] . In contrast, when GST-Bak BH3 was added, cytochrome c appeared in the supernatant within 0.5 hours of the start of incubation, and accumulated to a high level after 4 hours. Caspase activity in the supernatant was again coincident with the appearance of cytochrome c (Figure 5a ). In contrast to cytochrome c, cytochrome a, which is located in the inner mitochondrial membrane, did not appear in the supernatant fraction following either prolonged incubation of the extracts or addition of GST-Bak BH3. The majority of cytochrome c also remained in the heavy membrane fraction (Figure 5b ). We confirmed that addition of purified cytochrome c to the post-mitochondrial supernatant at levels similar to those released from mitochondria resulted in caspase activation (data not shown; see also [32] ). Therefore, BH3 domains seem to trigger capsase activation by acting at the control point regulating the release of cytochrome c.
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Figure 5
BH3 domains trigger release of cytochrome c (Cyt c) from mitochondria. (a) Egg extracts were incubated with PBS (control), GST-Bak BH3 or Bcl-2 for the times shown and then subjected to high-speed centrifugation (100,000 × g). The high-speed supernatant fractions were analysed by SDS-PAGE (15% acrylamide) and western blotting using antibodies to cytochrome c. The migration positions of protein standards are shown on the right with molecular masses in kDa. Caspase activity was assayed using Ac-DEVD-AMC as a substrate. (b) The experiment was carried out as in (a), except that both supernatant (HS) and heavy membrane pellet (HM) fractions were analysed by western blotting using antibodies to cytochrome c and cytochrome a. 
Discussion
In this study, we have carried out a functional analysis of the BH3 domains of Bcl-2 family proteins using a cell-free system based on Xenopus egg extracts. BH3 domains from Bak and Bax were found to be potent inducers of apoptosis in the presence of a membrane fraction; they trigger the activation of caspases and this process involves the release of cytochrome c from mitochondria. Apoptosisinducing activity was reproduced by peptides of 16 amino acids corresponding to the minimal region of the Bak, Bax and Bid BH3 domains required for binding to Bcl-x L [30] . This result demonstrates that this region is also sufficient for the induction of apoptosis. Although BH3 domains from all Bcl-2 family members exhibit sequence similarity, only BH3 domains from pro-apoptotic members of the family were able to trigger caspase activation in this cellfree system.
One or more critical functions of Bcl-2 family proteins are thought to be controlled by the formation of dimers between family members [19] . Studies using recombinant proteins have suggested that both homodimers and heterodimers are disrupted by peptides derived from Bax BH3 or Bak BH3 domains in binding assays in vitro [33] . It seems likely, therefore, that BH3 domains from pro-apoptotic proteins trigger apoptosis in Xenopus egg extracts by binding Bcl-2 family proteins that may be present in the extracts, disrupting anti-apototic dimers and mimicking the formation of pro-apoptotic dimers. This conclusion is supported strongly by our demonstration that a single amino-acid change which effectively abolishes the binding of a Bak BH3 peptide to Bcl-x L [30] completely abrogates its ability to induce apoptosis. In addition, our experiments titrating the activity of Bak BH3 against exogenous Bcl-2 show that the interaction of a BH3 domain with Bcl-2 blocks its ability to prevent apoptosis. Interestingly, this interaction does not turn Bcl-2 into a pro-apoptotic molecule. Excess pro-apoptotic BH3 domains may trigger apoptosis by releasing Bax or Bak-like proteins from suppression by endogenous Bcl-2-like proteins. It also remains possible that BH3 domains bind to pro-apoptotic proteins, perhaps activating their function. Together, these results emphasise the view that the control of caspase activation is critically dependent on the relative amounts of pro-apoptotic and anti-apoptotic homologues in the system.
The three-dimensional structure of BH3 peptides bound to Bcl-x L suggests that, in order to form a homodimer or heterodimer, a pro-apoptotic Bcl-2 family protein presents its BH3 domain to the recipient protein through a conformational change [30] . Given that pro-apoptotic BH3 domains bind in a pocket created by the BH1, BH2 and BH3 domains, it seems likely that an intact recipient protein is required. This conclusion is supported by our finding that the BH3 domain from Bcl-2 or a peptide derived from this domain has no activity in egg extracts. It is also in agreement with previous studies showing that Bcl-2 requires additional structures for its anti-apoptotic function when transfected into cells, and for heterodimerisation with Bax [18] . It seems that, while Bcl-2 acts as a recipient protein for BH3 domains from pro-apoptotic members of the family, it does not act as a BH3 donor itself. Our results show that a pro-apoptotic protein, unlike Bcl-2, does not need to contribute any structure to activate caspases and trigger apoptosis other than the minimal region of the BH3 domain required for binding to the recipient partner.
To trigger apoptosis in egg extracts, we find that BH3 domains require both membrane and cytosolic components. This result is also consistent with an interaction between BH3 domains and Bcl-2 family proteins in the extracts, given that Bcl-2 interacts with mitochondria in this system whereas other factors involved in caspase activation are cytosolic [13] . We have also demonstrated that BH3 domains trigger the rapid release of cytochrome c from mitochondria. Although the addition of cytochrome c to a post-mitochondrial supernatant is sufficient to activate soluble caspases in Xenopus egg extracts (this study and [32] ), it remains possible that additional factors released from mitochondria [34] are also involved in caspase activation by BH3 domains. The mechanism by which Bcl-2 family members regulate the release of cytochrome c is still unclear. Intriguingly, recent evidence suggests that Bcl-x L is able to interact directly with cytochrome c, and this interaction is disrupted by the related BH3-containing protein Bcl-x S [12] . BH3 domains may also disrupt the interaction of anti-apoptotic Bcl-2 family proteins with other proteins, such as a vertebrate CED-4 homologue [16] that regulates caspase activation ( Figure 6 ). Interestingly, Bax and Bak, as well as Bik/Nbk, a protein containing a BH3 domain, have been shown to prevent CED-4 binding to Bcl-x L [35] . One possibility is that the release of cytochrome c from mitochondria is coincident with the activation of an initiator caspase and dissociation of a complex assembled by a Bcl-2 family protein on the outer mitochondrial membrane. BH3 domains could also interfere with the proposed function of Bcl-2 family proteins as ion channels [20, [36] [37] [38] , but, as yet, it is unclear how this function might control the release of large molecules such as cytochrome c from mitochondria.
Whatever the precise mechanism of action of Bcl-2 family proteins, the ability of BH3 domains to trigger apoptosis in this cell-free system may have implications for the development of reagents to control apoptosis in cells. Importantly, we have shown that short, synthetic peptides comprising the core of the BH3 domain have apoptosisinducing activity. These small peptides are likely to be independent of controls over full-length pro-apoptotic proteins and may be mimicked by other small molecules that could be more easily introduced into cells. We would anticipate that such reagents would not show a non-specific toxicity towards cells, as might be the case with intact pro-apoptotic proteins that can form membrane pores. Rather, they may selectively kill cells in which apoptosis is actively suppressed by elevated levels of anti-apoptotic Bcl-2 family proteins.
Conclusions
BH3 domains from pro-apoptotic Bcl-2 family members and peptides derived from their sequences are potent activators of caspases and apoptosis in a model cell-free system. The mechanism of caspase activation by BH3 domains involves the release of cytochrome c from mitochondria. Our results provide support for a model in which the role of pro-apoptotic BH3 domains is to disrupt the function of anti-apoptotic Bcl-2 family members.
These results may open the way for the development of novel reagents to control apoptosis in cells. Such reagents may provide a useful strategy for intervention where resistance to apoptosis, or its inappropriate initiation, contributes to a disease.
Materials and methods

Xenopus egg extracts and DNA fragmentation analysis
Preparation of Xenopus egg extracts and DNA fragmentation analysis was carried out as described previously [8] . Where stated, extracts were fractionated into high-speed supernatant (HS) and heavy membrane (HM) fractions by centrifugation at 100,000 × g in a Beckman centrifuge using a TLA100 rotor. The HM fraction was washed in three volumes of membrane buffer (50 mM KCl, 250 mM sucrose, 2.5 mM MgCl 2 , 50 mM Hepes-NaOH, pH 8.0, 1 mM DTT, 1 µg/ml leupeptin, 1 µg/ml aprotinin) and resuspended in an equal volume of buffer.
Recombinant proteins and peptides
GST fusion protein constructs were made by amplifying the appropriate cDNA fragments using PCR and by cloning the fragments into pGEX vectors (Pharmacia). GST-Bak BH3 included amino acids 71-123, GST-Bax BH3 constructs included amino acids 50-78 and 50-105, GST-Bcl-2 BH3 included amino acids 86-111. Protein expression in Escherichia coli BL21 DE3 and purification on glutathione beads (Pharmacia) were carried out using standard techniques. The following peptides were obtained from Genosys or Zeneca Pharmaceuticals: Bak (amino acids 72-87), Bak mutant (as Bak, with alanine at position 78), Bax (amino acids 57-72), Bid (amino acids 84-99), Bcl-2 (amino acids 91-106) as described previously [30] . Bcl-2 (amino acids 1-218) tagged at the carboxyl terminus with six histidines was constructed using standard PCR techniques and cloned into vector ptb375 (Zeneca) for expression in E. coli BL21 DE3. Unless stated otherwise, recombinant proteins and peptides dissolved in a 10-fold dilution of phosphate-buffered saline (PBS) were added to egg extracts to 1/10 of the final volume to give a concentration of 0.1 mg/ml.
SDS-PAGE and western blot analysis
For analysis of poly (ADP-ribose) polymerase (PARP) cleavage, 10 µl samples were removed from the incubation with HeLa nuclei (see above) and spun in a microcentrifuge at 4000 r.p.m. The top 5 µl supernatant was then discarded and the remaining volume dissolved in SDS-PAGE gel sample buffer. Western analysis was performed using a PARP monoclonal antibody (gift from K. Caldecott), horseradish peroxidase-conjugated anti-mouse immunoglobulin and enhanced chemiluminescence (ECL) detection reagents (Amersham). For analysis of cytochrome c release from mitochondria, extracts were subjected to centrifugation at 100,000 × g in a Beckman centrifuge using a TLA100 rotor. Supernatants were then removed and added to SDS-PAGE sample buffer. Western analysis was performed using a cytochrome c monoclonal antibody (gift from R. Jemmerson) and standard ECL techniques. The monoclonal antibody was found to also react with another protein of > 50 kDa, as reported previously [11] .
Caspase activation assay
Extracts were incubated in the presence of peptides (0.1 mg/ml final concentration) or GST fusion proteins (also 0.1 mg/ml final Research Paper Regulation of apoptosis by BH3 domains Cosulich et al. 919
Figure 6
Model for the action of BH3 domains. A BH3 domain of a pro-apoptotic Bcl-2 family protein, such as Bax or Bak, binds to an anti-apoptotic family protein, such as Bcl-2 or Bcl-x L , at an intracellular membrane site, in this case the outer mitochodrial membrane. The heterodimeric complex triggers the release of cytochrome c from mitochondria by an unknown mechanism. It may also disrupt complexes with a CED-4 homologue (such as Apaf-1 [16] ). These events trigger the proteolytic processing and activation of an initiator caspase, which may be associated with the complex, leading to the activation of other caspases that bring about cytoplasmic and nuclear changes by cleavage of specific proteins. Caspase activity and many of the characteristic biochemical and morphological events of apoptosis are blocked by Ac-DEVD-CHO. concentration). At the times indicated, 5 µl samples were removed and incubated for exactly 10 min with 50 µM Ac-DEVD-AMC (Calbiochem). After incubation, samples were diluted to 2 ml in PBS. Cleavage of Ac-DEVD-AMC was detected with a fluorimeter using an excitation wavelength of 380 nm and an emission wavelength of 460 nm.
In vitro transcription/translation of proteins and binding assays
Human cDNA clones of human Bcl-2, Bcl-x L (encoding amino acids 1-211), Bax (encoding amino acids 1-171) and Bak in pcDNA3 (Invitrogen) were translated using a coupled transcription/translation system (Promega) in the presence of T7 polymerase and [ 35 S]-methionine according to the manufacturer's instructions. Binding of GST-BH3 fusion proteins to glutathione beads (Pharmacia) was carried out in binding buffer (20 mM Tris pH 8.0, 50 mM NaCl, 0.1 % Triton, 10 % glycerol) according to the manufacturer's instructions. Briefly, 20 µl beads were bound to 5 µg of each GST fusion protein at 4°C for 30 min. Beads were washed three times in binding buffer, before addition of equal amounts of [ 35 S]-methionine-labelled reticulocyte lysates from in vitro translation reactions and incubation at 4°C for 60 min. Beads were washed three times in binding buffer before addition of 20 µl GSB (50 mM Tris pH 6.8, 100 mM DTT, 2% SDS, 0.1% bromophenol blue) and analysis by SDS-PAGE. Gels were dried and analysed by autoradiography.
